首页> 美国卫生研究院文献>Science Advances >How and when does an anticancer drug leave its binding site?
【2h】

How and when does an anticancer drug leave its binding site?

机译:抗癌药如何以及何时离开其结合位点?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Obtaining atomistic resolution of drug unbinding from a protein is a much sought-after experimental and computational challenge. We report the unbinding dynamics of the anticancer drug dasatinib from c-Src kinase in full atomistic resolution using enhanced sampling molecular dynamics simulations. We obtain multiple unbinding trajectories and determine a residence time in agreement with experiments. We observe coupled protein-water movement through multiple metastable intermediates. The water molecules form a hydrogen bond bridge, elongating a specific, evolutionarily preserved salt bridge and enabling conformation changes essential to ligand unbinding. This water insertion in the salt bridge acts as a molecular switch that controls unbinding. Our findings provide a mechanistic rationale for why it might be difficult to engineer drugs targeting certain specific c-Src kinase conformations to have longer residence times.
机译:获得从蛋白质上解脱出来的药物的原子分辨率是一个广受欢迎的实验和计算挑战。我们报告了使用增强的采样分子动力学模拟以全原子分辨率从c-Src激酶获得的抗癌药物dasatinib的释放动力学。我们获得了多个解脱的轨迹,并根据实验确定了停留时间。我们观察到通过多个亚稳中间体的耦合的蛋白质-水运动。水分子形成氢键桥,延长了特定的,进化上保留的盐桥,并使配体解键必不可少的构象变化。盐桥中的这种水插入作用是控制解键的分子开关。我们的发现为为什么可能难以设计针对某些特定c-Src激酶构象的药物以具有更长的停留时间提供了机械原理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号